Paediatrics News & Research | Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Paediatrics

children and covid

Similar factors associated with COVID-19 severity in children and adults

probiotics and eczema

Probiotics reduce risk of developing atopic eczema

opioids and young people

Half of paediatric opioid prescriptions deemed high risk

peanut allergy

Efficacy of Palforzia in childhood peanut allergy increases over time

medulloblastoma

Survival benefit from carboplatin in children with high risk medulloblastoma

childhood vaccination

Review shows no increased risk of allergic disease after childhood vaccination

systemic juvenile idiopathic arthritis

Early biologic use in systemic juvenile idiopathic arthritis reduces need for steroids

Cosentyx approved in the US for psoriasis in children

Cosentyx receives FDA approval for use in children and adolescents

Therapeutic drug monitoring of adalimumab in paediatric Crohn's disease

Monitoring adalimumab levels valuable for assessing remission in children with Crohn’s disease

MHRA extends approval of Pfizer-BioNTech vaccine

MHRA approves Pfizer-BioNTech vaccine for 12-15-year-olds

COVID usual symptoms lacking in children

Only a quarter of children with COVID-19 have typical symptoms

malaria vaccine candidate achieves efficacy in children

Malaria vaccine candidate achieves 77% efficacy in children